Literature DB >> 24954887

How I treat ovarian cancer in older women.

Stuart M Lichtman1.   

Abstract

Advancing age in patients with epithelial ovarian cancer is a risk factor for decreased survival. The exact cause is unknown but part of this may be due to less than adequate therapy for these patients. To optimize treatment, this paper presents the available data for therapy and my own approach in the management of this disease. For optimal outcomes, there also needs to be a close collaboration between subspecialists (gynecologic oncology, medical oncology, pathology) in all aspects of treatment planning. Progression-free and overall survival can be prolonged and patients' quality of life can be maintained with appropriate management.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carboplatin; Cisplatin; Elderly; Intraperitoneal; Ovarian cancer; Paclitaxel; Serous ovarian cancer

Mesh:

Year:  2014        PMID: 24954887     DOI: 10.1016/j.jgo.2014.06.001

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  3 in total

1.  Circulating VEGF as a biomarker for diagnosis of ovarian cancer: a systematic review and a meta-analysis.

Authors:  Bin Liang; Qun He; Liansheng Zhong; Shaocheng Wang; Zhongcheng Pan; Tianjiao Wang; Yujie Zhao
Journal:  Onco Targets Ther       Date:  2015-05-15       Impact factor: 4.147

Review 2.  Recent advances in cancer surgery in older patients.

Authors:  Siri Rostoft; Riccardo A Audisio
Journal:  F1000Res       Date:  2017-07-27

Review 3.  Chemotherapy of ovarian cancer in elderly patients.

Authors:  Tiffany A Troso-Sandoval; Stuart M Lichtman
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.